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Various mutation assisted drug resistance evolved in Plasmodium falciparum strains and insecticide 
resistance to female Anopheles mosquito account for major biomedical catastrophes standing against 
all efforts to eradicate malaria in Sub-Saharan Africa. Malaria is endemic in more than 100 countries and 
by far the most costly disease in terms of human health causing major losses among many African 
nations including Nigeria. The fight against malaria is failing and DNA microarray analysis need to keep 
up the pace in order to unravel the evolving parasite’s gene expression profile which is a pointer to 
monitoring the genes involved in malaria’s infective metabolic pathway. Huge data is generated and 
biologists have the challenge of extracting useful information from volumes of microarray data. 
Expression levels for tens of thousands of genes can be simultaneously measured in a single 
hybridization experiment and are collectively called a “gene expression profile”. Gene expression 
profiles can also be used in studying various state of malaria development in which expression profiles 
of different disease states at different time points are collected and compared to each other to establish 
a classifying scheme for purposes such as diagnosis and treatments with adequate drugs. This paper 
examines microarray technology and its application as supported by appropriate software tools from 
experimental set-up to the level of data analysis. An assessment of the level of microarray technology 
in Africa, its availability and techniques required for malaria eradication and effective healthcare in 
Nigeria and Africa in general were also underscored. 
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INTRODUCTION 
 
A DNA microarray (also commonly known as gene or 
genome chip, DNA chip, or gene array) is defined by 
Wikipedia encyclopedia as a collection of microscopic 
DNA spots, commonly representing single genes, array-
ed on a solid surface by covalent attachment to chemi-
cally suitable matrices. In the paper of Chen (2006), DNA 
microarray is defined as an array of tens of thousands of 
molecular sequences (that is, probes) mobilized in the 
form of DNA on a solid and planar platform on a micro-
scopic and high-density scale and can be used in 
hybridization experiments for the parallel measurement of 
the quantity of bound homologous sequences in biolo-
gical samples. 
However, we define DNA Microarray as a technology 
with a grid of nucleic acid molecules of known composi-
tion called probe, placed/immobilized on a solid substrate 
or slide and used to hybridize messenger RNA (mRNA) 
from a target cell or tissue of unknown composition to 
reveal changes in gene expression relative to a control 
sample. By hybridization, we mean that the four nitro-
genous bases of the probe pair up with their compli-
mentary nitrogenous bases in the unknown or tested 
sample, such that Adenine(A) pairs with Thymine 
(T)/Uracil(U) and Cytosine(C) pair Guanine(G). Micro-
array technology, which is also known as “DNA chip” 
technology, allows the expression of many thousands of 
genes to be assessed in a single experiment. 
The use of microarrays for gene expression profiling 
was first published in Schena et al. (1995) and the first 
complete eukaryotic genome (Saccharomyces cere-
visiae) on a microarray was published in 1997 (Tatusov 
et al., 1997). A microarray experiment involves monitoring 
gene expressions as the cell undergoes some biological 
processes. These experiments are often used  to measure 
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Figure 1. Process of Protein Synthesis (DNA->mRNA->Protein). 
 
 
 
gene expression and therefore are able to detect 
differences in gene expression between two populations 
of cells; a test population (disease cell or tissue) versus a 
control population (normal cell or tissue). However, the 
experimental and control gene expression values ratio is 
computed and used. Huge data is generated and biolo-
gist has the challenge of extracting useful information 
from volumes of microarray data. Expression levels for 
tens of thousands of genes can be simultaneously mea-
sured in a single hybridization experiment and are collec-
tively called a “gene expression profile”. 
The protozoan Plasmodium falciparum makes an excel-
lent organism for this type of experiment because of its 
devastating economic importance coupled with the fact 
that its genome has been sequenced and ORFs (Open 
Reading Frames) have been determined. Drug resistance 
in evolving P. falciparum strains and insecticide resis-
tance to female Anopheles mosquitoes accounts for 
major biomedical catastrophe standing against all efforts 
to eradicate malaria in Sub-Saharan Africa. Among these 
diseases, malaria is endemic to more than 100 countries 
(Le Roch et al., 2003) and by far the most costly in terms 
of human health causing major losses among many 
African nations including Nigeria. It is caused by proto-
zoan parasites of the genus Plasmodium and infects 
approximately 500 million people annually, killing more 
than one million, mainly children and pregnant women in 
Africa (Le Roch et al., 2003). 
The fight against malaria is failing (Osamor, 2009) and 
microarray analysis need to keep up the pace to unravel 
the evolving parasite’s gene expression profile which is a 
pointer to monitoring the genes involved in malaria’s 
infective metabolic pathway. Gene expression profiling 
has been commonly used to study the pathogen’s or 
host’s responses to each other or to the external stimuli 
such as drug or vaccine treatments. Gene expression 
profiles can also be used in studying various state of 
malaria development in which expression profiles of 
different disease states at different time points are 
collected and compared to each other to establish a 
classifying scheme for purposes of diagnosis and 
treatments with adequate drugs. 
Each particular cell or tissue in the body has a nucleus 
bearing a number of chromosomes with genes containing 
information in its DNA, about the type of needed protein 
to be produced by the cell. The characteristic of produc-
ing different sets of proteins passes the process called 
transcription by copying the DNA genetic information of 
the needed protein to form mRNA (an intermediate pro-
duct) and finally to protein biomolecules through transla-
tion as shown in Figure 1. 
This molecular biology dogma, DNA => mRNA => 
Protein is the basis of microarray technology as DNA 
microarray measures mRNA transcript as gene expre-
ssion level. DNA code (genetic code) which is a triplet 
codon arising from a combination of three(3) of the 
four(4) nitrogenous bases: Adenine(A), Thymine(T), Gua-
nine(G), and Cytosine(C) form the type of amino acid or 
protein to be produced while a stop codon terminates the 
process. 
 
 
PATHOGENICITY OF P. FALCIPARUM MALARIA 
 
When a plasmodium-infected mosquito bites a person, it 
transmits the sporozoites on its salivary glands into the 
subcutaneous layer of the skin into the bloodstream 
which migrates to the liver for exo-erythrocytic development 
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Figure 2. Life Cycle of Plasmodiun falciparum in Liver and Red Blood Cell (Miller et al., 2002). 
 
 
 
by asexual means (Figure 2). The co-receptor on 
sporozoites that mediates invasion involves, in part, the 
thrombospondin domains on the circumsporozoite protein 
(CSP) and on thrombospondin-related adhesive protein 
(TRAP). These domains bind specifically to heparin on 
hepatocytes. Inside the hepatocyte, each sporozoite 
develops into tens of thousands of merozoites, which can 
each invade an RBC on release from the liver. Disease 
begins only once the asexual parasite multiplies in RBCs, 
producing around 20 merozoites per mature parasite 
within 48 hours, with each merozoite able to invade other 
RBCs.. This is the only gateway to disease. A small 
proportion of asexual parasites is converted to gameto-
cytes that are essential for transmitting the infection to 
others through female anopheline mosquitoes (Miller et 
al., 2002).  
 
 
Invasion of RBCs and binding of parasitized RBCs to 
vascular endothelium and placenta 
 
In respect to RBC invasion, Miller et al. (2002) noted that 
what remains completely unknown is which merozoite 
surface molecules recognize the RBC surface and then 
signal the start of the invasion process. The parasite 
induces a vacuole derived from the RBC’s plasma 
membrane and enters the vacuole. Three organelles on 
the invasive (apical) end of the parasite (rhoptries, 
micronemes and dense granules) define the phylum 
Apicomplexa. Receptors that mediate invasion of RBCs 
by merozoites and invasion of liver by sporozoites are 
found in micronemes, on the cell surface, and in 
rhoptries. Identifying the signaling pathways that release 
organelle contents on contact with a host RBC is a critical 
issue in parasite biology (Figure 2). Malaria parasites 
have intracellular signaling pathways mediated by 
phosphoinositide, cyclic AMP and calcium- dependent 
mechanisms. Invasion events include releasing essential 
molecules from apical organelles and initiating the actin-
myosin moving junction that brings the parasite inside the 
vacuole that forms in the RBC. 
Although other parasite proteins on the merozoite 
surface and in apical organelles have been proposed as 
receptors, there is no direct evidence so far. Because 
invasion is such a complex series of events from RBC 
binding, to apical reorientation, to entry, it seems likely 
that several proteins are required for efficient invasion. 
For example, evidence has suggested that RBC invasion 
requires the cleavage of a surface protein on the RBC by 
an unknown parasite serine protease (Miller et al. (2002). 
Thus, the molecular and cellular events surrounding each 
step in invasion still remain to be elucidated. 
Understanding these pathways will give insight into 
parasite virulence and will facilitate rational vaccine 
design against merozoite invasion. A single parasite 
protein, P. falciparum erythrocyte membrane protein 1 
(PfEMP1), which is expressed at the infected erythrocyte 
surface mediates parasite binding to all the various 
receptors. PfEMP1 is encoded by the large and diverse 
var gene family that is involved in clonal antigenic 
variation and has a central role in P. falciparum 
pathogenesis.  Adherence protects the parasite from des- 
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Figure 3. Design of Oligonucleotide probe (feature) showing its location in the Probe set and 1 gene represented by 1 
probe.       
 
 
 
truction, as non-adherent mature parasitized RBCs are 
cleared rapidly in the spleen.  
 
 
DNA MICROARRAY TECHNOLOGY 
 
Microarray fabrication and probe design 
 
Microarrays fabrication is achieved through two techno-
logies and involves either DNA deposition or in situ syn-
thesis. While the deposition method allows the deposition 
of PCR-amplified cDNA clones and printing of already 
synthesized oligonucleotides with fine-pointed pins onto 
glass slides, in situ manufacturing is by photolithography 
using pre-made masks, ink-jet printing, or electrochemis-
try on microelectrode arrays. 
Let nt be nucleotides, nucleic acid microarrays primarily 
use short oligonucleotides (15 - 25 nt), long oligo-
nucleotides (50 - 120 nt) and PCR-amplified cDNAs (100 
- 3,000 base pairs) as array elements. Short probes are 
possible because they are selected using special 
algorithms to run on already sequenced genome data to 
find unique sequences that serves as a representative of 
each gene in an organism.  Figure 3 shows a probe with 
both Perfect match (PM) and Mismatch (MM) pair aligned 
to a reference mRNA that is provided  from information 
on sequenced organism. 
A probe cell also called feature contains 25 nucleotides 
and can be a PM or MM. Usually probes are manufac-
tured in pairs such that PM has same sequence of 25 
nucleotides as the MM except for one nucleotide at the 
middle (13th ) position which are complementary. PM 
hybridizes with the experimental sample to measure the 
degree of signal intensity while the MM hybridizes to give 
value for background subtraction which improves data 
accuracy. One or more probes can be used to represent 
a gene and a typical Affymetrix probe contains about 16 - 
20 probes in a probe set. 
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Figure 4. Photolithographic manufacture of Oligonucleotide array. 
 
 
 
Photolithographic manufacturing process produces 
GeneChip arrays with millions of probes on a small glass 
chip or substrate called wafer or array. The photolitho-
graphic process begins by coating a 5 x 5 quartz wafer 
with a light-sensitive chemical compound that prevents 
coupling between the wafer and the first nucleotide of the 
DNA probe being created. 
Lithographic masks are used to either block or transmit 
light onto specific locations of the wafer surface. The 
surface is then flooded with a solution containing either 
adenine, thymine, cytosine, or guanine, and coupling 
occurs only in those regions on the glass that have been 
deprotected through illumination (Affymetrix). It continues 
till probes reach their full length of about 25 nucleotides 
(Figure 4) with about 1.3 million features on one array. 
 
 
Experimental design  
 
Microarray experimental design allows researchers to 
test and vary the input variables that impact on the micro-
array experiment to get correct output. These involve 
three major principles that entail: Replication, Randomi-
sation and Blocking. In replication, duplicate or repeat of 
the same experiment more than once but varying one 
factor like changing the location of same probe on the 
array to monitor its behaviour. This gives estimate of the 
experimental error if the observed differences in the data 
are significant. Randomisation means that experimental 
data can be monitored by allowing probes to be placed 
on the array in no particular order (random). Blocking 
allows the experimenter to keep all nuisance factors (fac-
tors that are not of interest but can affect the experi-
mental outcome) while the interesting factor is varied e.g. 
Slide is a block (Draghici, 2003). 
Some microarray specific types of experimental design 
include reference design and loop design. In reference 
design many sample conditions or timepoints t1, t2,…,tn 
are pairwise compared to only one reference sample, ref,  
that samples 1 to n while ref is measured n times 
(Quackenbush, 2005). Variability error is introduced by 
dyes and can be stabilized by swapping the R and G 
dyes to the optimized measurement (twice) for each sam-
ple and thereby collect more information on interesting 
data using same 2n arrays. This is the loop design. 
Vinciotti et al. (2005) studied the relative efficiency of both 
a loop and a reference design using the same RNA pre-
parations. Their results of these experiments show that 
(1) the loop design attains a much higher precision than 
the reference design, (2) multiplicative spot effects are a 
large source of variability, and if they are not accounted 
for in the mathematical model, for example, by taking log-
ratios or including spot effects, then the model will per-
form poorly. 
 
 
cDNA microarray experiment 
 
Spotted or cDNA or two-channel microarrays consists of 
thousands of individual DNA sequences called probe 
printed in a  high  density  array  on  a  glass  microscopic  
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Figure 5. cDNA microarray experiment. 
 
 
 
slide using a robotic arrayer. The process of probe print-
ing is shown in Figure 5 during array preparation. 
During target preparation mRNA is extracted from two 
samples called A and B to be studied. These targets 
mRNA samples are reverse-transcribed into cDNA and 
labeled using different fluorescent dyes where Cy3 repre-
sents green and Cy5 represents red Figure 5. Labeled 
samples are mixed together and competitively hybridized 
with the probe on the array to give rise to image for 
analysis. Relative abundance of spotted DNA sequences 
or probe in two samples may be assessed by monitoring 
the differential hybridization of the two samples to the 
sequences on the array. 
 
 
Oligonucleotide microarray experiment 
 
Once the microarray is constructed, oligonucleotide chip 
experiment requires the preparation of sample for 
GeneChip arrays. Messenger RNA (mRNA) is extracted 
from the cell and converted to cDNA as shown in Figure 
6. It then undergoes amplification and labeling where the 
target mRNA population is labeled, typically with a 
fluorescent dye, so that hybridization to the probe spot 
can be detected when scanned with a laser (Gibson, 
2003).  Fragmentation and hybridization of the sample to 
25-mer oligos on the surface to the chip takes place 
under an appropriate temperature. 
The next step is the washing of unhybridized material 
and the chip is scanned in a confocal laser scanner and 
the image analyzed by computer. This approach provides 
a way to use directly the growing body of sequence 
information for experimental investigations (Wosik, 2006). 
However, one sample is hybridized on one array for one-
colour chanelled oligonucleotide microarray unlike two-
colour chanelled cDNA microarray capable of hybridizing 
2 distinctly labeled(R and G) samples on one array.  
 
 
Microarray images and data analysis 
 
After competitive hybridization, images of slides are taken 
by microarray scanner which makes florescent measure-
ment of each dye. The ratio of the florescence intensities 
for each spot is indicative of the relative abundance of the 
corresponding DNA sequence in the nucleic acid sam-
ples. cDNA microarray image processing steps generate 
two main quantities R (red) and G (green) for each spot 
on the array, thereby measuring transcript abundance for 
red and green mRNA labeled samples. The R and G 
values are usually combined or normalized into a single 
log-intensity ratio, log2 R/G, measuring relative transcript 
abundance in the two samples. A positive log-ratio de-
notes gene over-expression while a negative log-ratio 
denotes gene under-expression. Normalisation needs to 
be done before clustering for further data  analysis  so  as  
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Figure 6. Oligonucleotide chip experiment. 
 
 
 
to identify and remove systematic sources of variation 
such as different labeling efficiencies, scanning pro-
perties of dyes used, and print tip of robotic arrayer dur-
ing probe spotting. 
Microarray gene expression profiles are often subjected 
to cluster analysis and pathway mapping to unveil groups 
of co-regulated genes - a practice that is referred to as 
regulatory network and metabolic pathways discovery or 
reconstruction. A common early step in microarray data 
analysis is log transformation. Typically, log base 10 is 
used; however, log base 2 or natural log will work equally 
well. Log transformation has several important effects on 
the data. The most critical reason to log transform micro-
array data is that some of the error in the signal intensity 
measurement increases as the magnitude of signal 
intensity increases. That is, small numbers have less 
error in an absolute sense than higher numbers. Fortu-
nately, higher numbers have roughly the same percent-
tage error as small numbers. This roughly constant factor 
can be simply calculated and subtracted to normalize the 
data once the signals have been log transformed. There 
are additional effects of logging that make log trans-
formed microarray data more closely fit statistical 
assumptions when applying statistical test methods. Log 
transformation makes data more symmetrical, one of the 
standard assumptions of normality. Log transformation 
also reduces the influence of a single measurement. 
Means on a log scale are more like geometric means, 
which are resistant to the effects of outliers, and it follows 
that outliers result in better estimates of variance. So, by 
log transforming data, common statistical methods are 
made more reasonable and provide more accurate 
insights to the biologist (Affymetrix, 2001). 
The relative difference between a Perfect Match and its 
Mismatch is Discrimination Score [R]: R= (PM-
MM)/(PM+MM))(Affymetrix). A qualitative measurement 
indicating if a given transcript is detected (present), not 
detected (absent), or marginally detected (marginal) is a 
measure of value[R]. Statistical model both parametric 
and non-parametric such as Students t-test, ANOVA, 
Mann-Whitney test, f-distribution, Wilcoxon signed rank 
test etc form the basis of several formulae and algorithms 
that are used to compute differential gene expressions, 
image segmentations, normalizations and clustering 
algorithms. However, many software tools are available 
to serve as resource that supports most microarray ana-
lysis functions. 
 
 
Microarray software support 
 
There are various commercial and open source software 
products existing currently to support DNA microarray 
analysis. For this work, we consider a free open source 
software TM4 (Saeed et al., 2003) from The Institute of 
Genomic Research (TIGR) used for cDNA microarray 
and a commercial GeneChip Operating Software (GCOS)  
  
 
 
 
from Affymetrix and dChip software for Oligonucleotide 
microarray. 
 
TM4: TM4 suite of tools consists of four major 
applications, Microarray Data Manager (MADAM), 
TIGR_Spotfinder, Microarray Data Analysis System 
(MIDAS), and Multiexperiment Viewer (MeV), as well as a 
Minimal Information about a Microarray Experiment 
(MIAME)-compliant MySQL database, all of which are 
freely available to the scientific research community at 
http://www.tigr.org/software. The MADAM data entry 
interface provides access to data associated with a 
microarray study. It has a navigation panel on the left-
hand side which leads users through the process of data 
entry during a microarray experiment. TIGR Spotfinder 
provides image processing with direct connections to the 
microarray database. MIDAS allows users to define data 
normalization and filtering protocol using a simple 
graphical scripting interface. The diagram on the left 
shows the steps in the analysis to be carried out; the 
panel on the right allows users to enter parameters for 
each stage in the analysis. MeV allows users to apply a 
number of sophisticated data mining tools to their array 
data and provides integrated graphical depictions of the 
results of the analyses conducted. Three of the TM4 
applications, MADAM, MIDAS, and MeV, were developed 
in Java and have been tested on Microsoft® Windows, 
Linux, Unix, and MacOS X platforms; TIGR Spotfinder 
was written in C/C++ and runs only on Windows systems 
(Saeed et al., 2003). 
 
GeneChip Operating Software (GCOS): GCOS is a 
proprietary software currently used to analyse Affymetrix 
Oligonucleotide microarray after hybridization of the 
probe with target samples since Microarray Suite (MAS) 
has been discontinued. Image of the slide is captured via 
a scanner and expression values are generated into a 
*.dat file (Data File). The software derives the *.cel file 
(Cell Intensity File) from a *.dat file and automatically 
creates it upon opening a *.dat file. It contains a single 
intensity value for each probe cell delineated by the grid 
(calculated by the cell analysis algorithm). Chip File 
*.chp, the output file generated from the analysis of a 
probe array contains qualitative and quantitative 
information for every probe set. Report File *.rpt is a text 
file summarizing data quality information for a single 
experiment and is generated from the analysis of output 
file (*.chp). There are also other output file involved in the 
use of GCOS such as *.cab (Cab File) which is a com-
pressed file that is a backup copy of a process or publish 
database, project, sample, and/or experiment. *.txt and 
*.xls are standard format for text files and spreadsheet 
files and GCOS exports text in these file formats. The  
library files (probe information) *.cif, *.cdf, and *.psi 
contain information about the probe array design cha-
racteristics, probe utilization and content, and scanning 
and analysis parameters. These files are unique for each 
probe array type.  Fluidics  Files*.bin,  *.mac. T he fluidics  
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files contain information about the washing, staining, 
and/or hybridization steps for a particular array format. 
 
DNA-Chip analyser (dChip): DNA-Chip Analyzer 
(dChip) is a software package for probe-level and high-
level analysis of Affymetrix gene expression microarrays 
and SNP microarrays (Li and Wong, 2001a; Li and Wong, 
2001b; Lin et al., 2004). However, gene expression or 
SNP data from other microarray platforms can also be 
analyzed by importing as external dataset. High-level 
analysis in dChip includes comparing samples, hierarchi-
cal clustering, Loss of Heterozygosity (LOH) and copy 
number analysis of SNP arrays. To use dChip, the user 
needs to provide Affymetrix array data files (in CEL or 
DAT format, or see public CEL files), and the CDF file 
(Chip Description File). Obtain the dChip and gene 
information files and CEL file if required into local 
directory and double click to start dChip program. Affy 
conversion tool will convert all CEL files in a directory 
from version 4 to version 3, while leaving the file name 
the same. You can check the CEL file change in size to 
confirm if conversion is done and also ensure that CEL 
files are not read-only. If conversion fails DAT files can 
also be read by dChip instead of CEL files. 
To read in cDNA array data, an external data file with 
every two columns as the green and red channel 
intensities from one array (e.g. obtained from GenePix 
GPR file), is read into dChip by “Analysis/Get external 
file” before continuing with data analysis. dChip is a 
freeware, single executable program developed on 
Windows 2000 but preferring windows NT/XP computers 
with 512 Megabytes memory for maximal operation. 
dChip is written in Visual C++ 6.0 and uses Windows-
specific functions for graphic tasks, and the source code 
is freely available for academic purposes.  
 
Compilation of P. falciparum and microarray software 
resources: Computer brought an ease in handling 
microarray technology tasks at nearly all stages through 
the provision of abundant software resources. The 
inexhaustive list of Plasmodium and microarray software 
resources (Coppel et al., 2004; http:// 
www.wellcome.ac.uk/assets /wtx033402.pdf) is depicted 
in Tables 1 - 5. 
 
 
APPLICATION OF DNA MICROARRAYS 
TECHNOLOGY AND RELATED WORKS ON MALARIA 
 
Gene expression profiling applications 
 
Gene expression profiling applications includes: patho- 
genesis studies, pathogen’s responses to drugs; pathogen’s 
responses to host, host’s responses to infection, host’s 
responses to treatments and host response to vaccines. 
Expression levels for tens of thousands of genes can be 
simultaneously measured in a single hybridization experi-
ment and are collectively called a “gene expression 
profile”. In the gene expression profiling experiments,  the  
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Table 1. Plasmodium falciparum general information sites. 
 
Name URL 
PlasmoDB  http://www.PlasmoDB.org 
P. falciparum GeneDB site  http://www.genedb.org/genedb/malaria/index.jsp 
TIGR parasites database  http://www.tigr.org/tdb/parasites/ 
Sanger Institute parasite genomes project  http://www.sanger.ac.uk/Projects/Protozoa/ 
Sanger institute P. falciparum genome project http://www.sanger.ac.uk/Projects/P_falciparum/ 
Malaria full length complementary DNA project http://fullmal.ims.u-tokyo.ac.jp/ 
KEGG implementation of the P. falciparum metabolic 
pathways 
 http://www.genome.ad.jp/dbget- bin/www_bfind?p.falciparum 
PlasmoCyc genome pathway database  http://plasmocyc.stanford.edu/ 
Malaria parasite metabolic pathways  http://sites.huji.ac.il/malaria/ 
WHO/TDR malaria database  http://www.wehi.edu.au/MalDB-www/who.html 
NCBI malaria genetics and genomics  http://www.ncbi.nlm.nih.gov/projects/Malaria/ 
DeRisis laboratory malaria transcriptome database  http://malaria.ucsf.edu/index.php 
Structural genomics of parasitic protozoa consortium  http://depts.washington.edu/sgpp 
 
 
 
Table 2. Microarray information sites. 
 
Name URL 
ArrayExpress repository for microarray data.  http://www.ebi.ac.uk/arrayexpress   
Microarray gene expression data society 
homepage 
http://www.mged.org,http://www.microarrays.org, 
http://microarrayworld.com, 
http://www.deathstarinc.com/science/biology/chips.html 
 
 
 
Table 3. Spot information extraction. 
 
Name Description 
GenePix (http://www.axon.com 
/gn_Genomics.html) 
Spot extraction information from TIFF files 
Microarray Suite (MAS 5.0)  Old and discontinued commercial software for Affymetrix oligonucleotide 
microarray used during image analysis and generation of expression values. 
GeneChip Operating Software (GCOS) Latest commercial software for Affymetrix oligonucleotide Microarray for image 
analysis and generation of expression values. 
 
 
biological samples that the probes are designed to 
interrogate are RNA extracted from cells or tissues. 
These types of experiments answer the question of “what 
genes and how much of them are expressed in the 
biological sample?”. The RNA molecules are first con-
verted to cDNA by reverse transcription and labeled with 
a fluorescent dye. The expression level of a gene are 
measured as the light intensities emitted, after excitation 
with laser light, by the fluorescent dye attached to the 
cDNA that bound the  homologous  probes  on  the  
array (Chen, 2006). 
Gene expression profiles of the host to pathogen may 
also be used in diagnosis for identifying possible patho-
gens. DNA microarray technology enables scientists to 
perform global survey of novel virulence factors, antimi-
crobial drug resistance genes, and potential vaccine tar-
gets by monitoring the transcription profiles of  the  patho-  
gens in response to host environments. 
Osamor (2009) reviewed recent studies that applied 
microarray approach to monitor gene expression of 
malaria pathogen, Plasmodium falciparum (put in italic) in 
the host cells for identification of potential vaccine 
candidates or drug targets. Daily et al. (2005) studied the 
gene expression profiles of P. falciparum that was 
isolated from blood samples of infected patients and 
compared them (Daily et al. 2007) with the in vitro profiles 
of a reference P. falciparum strain at the ring stage (Le 
Roch et al., 2003). A new family of hypothetical protein 
that may encode surface antigens was found to be over-
expressed in the in vivo samples, making these potential 
candidates for vaccine development. 
Gaur et al. (2006) identified new virulence genes by 
comparing gene expression profiles between two P. 
falciparum  clones.  The  P.  falciparum  Dd2,  a  parasitic 
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Table 4.  Normalisation and data analysis software. 
 
Name Description 
TM4 software- (Saeed et al., 2003; 
http://www.tigr.org/software). 
TIGR suite of programs for data analysis and visualisation. In 
particular, MIDAS and MEV are useful for analyzing cDNA 
Microarray experiment 
dChip software A freeware that contains suite of program for that supports 
Affymetrix gene chip (oligonucleotide) microarray experiment. 
GeneSpring – 
(http://www.silicongenetics.com). 
commercial and comprehensive multipurpose data 
analysis/visualization software 
Bioconductor 
(http://www.bioconductor.org and 
http://www.r-project.org). 
Numerous advanced statistical analysis and data visualisation 
programs that run under the R-project language 
SAM (Significant Analysis of 
Microarray) 
(http://www-
stat.stanford.edu/~tibs/SAM) 
Popular and easy to use Excel plug-in for statistical analysis of 
microarray data 
MAANOVA  
(http://www.jax.org/staff/churchill/labsit
e/software/Jmaanova/index.html) 
Advanced statistical analysis of cDNA microarray data 
Resourcerer  
(http://pga.tigr.org/tigr-
scripts/magic/r1.pl). 
Identify common transcripts between different array platforms 
 
 
 
Table 5. Functional tools applicable to microarray data. 
 
Name Description 
EASE – 
(http://david.niaid.nih.gov/david/ease.htm). 
Software for functional classification and analysis of gene lists. 
GO (http://geneontology.org). Biological/functional gene annotations. 
EXPANDER 
(http://www.cs.tau.ac.il/~rshamir/expander/
expander.html). 
Software for functional/promoter analysis of clustered gene lists. 
KEGG (http://www.genome.jp/kegg/). Biological pathways and gene annotations.  
GenMAPP- (http://www.genmapp.org). Biological pathways and gene annotations. 
Ingenuity (http://www.ingenuity.com).  Commercial, comprehensive hand-curated resource for gene 
function annotation and analysis of gene lists. 
Biolayout  from Enright and Ouzounis 
(2001) 
 
A java-based general networks visualization tool with custom 
layout algorithm that preferentially places functionally similar 
nodes together so that biologically relevant functional clustering 
is more easily seen.  
Pathway Tools Software for studying molecular pathways from Karp et al. 
(2002).  
 
 
 
clone which requires sialic acid residues on the erythro-
cyte surface for successful invasion, is capable of under-
going a genotypic switch to become a subclone Dd2 
(NM), which can invade erythrocytes without the sialic 
acid residues. By comparing the expression profiles of 
these two parasitic clones, four novel genes were initially 
identified to be up-regulated in the sialic independent 
clone Dd2 (NM). Two of these genes, PfRH4 and PEBL, 
were confirmed by RT-PCR and the expression of PfRH4 
at protein level was further confirmed to be only in Dd2 
(NM) (Chen, 2006). 
 Genotyping applications 
 
Genotyping applications includes pathogen identification,  
drug resistance survey, host susceptibility, pathogen 
cataloging and vaccine re-evaluation. In the genotyping 
experiments, the targets are DNA extracted from the  bio- 
logical samples and the probes are designed to survey 
the sequence variations in or among the samples. “Single 
nucleotide polymorphism (SNP) microarray” is an exam-
ple of genotyping microarray. A variation of the SNP 
microarray is  called  “sequencing  microarray”  or  “rese- 
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sequencing microarray” and can be used to re-sequence 
a specific region of a closely related genome, of which 
the sequences have to be decoded. 
The most direct and perhaps also the most widely used 
applications of DNA microarray technology in infectious 
diseases fall in this category. DNA microarrays allow 
quick identification of the pathogens based on the unique 
sequence signature detectable by the large number of 
the probes on the array. 
A good example is the identification of a new corona 
virus that caused the severe acute respiratory syndrome 
(SARS) epidemic outbreak in 2003. Before the outbreak, 
Wang et al. (2003) had devised a microarray intended for 
detecting the widest possible range of both known and 
unknown viruses. This viral microarray platform contained 
probes representing all the approximately 1,000 known 
virus sequences at the time from GenBank. In March 
2003, DeRisi and Wang, then a postdoc in DeRisi’s lab at 
the University of California, San Francisco, used this 
microarray to quickly identify the viral agent in SARS 
samples as a new type of corona virus. 
 
 
Other microarray related works on malaria 
 
Bozdech et al. (2003b) developed a software package, 
ArrayOligoSelector, to design an open reading frame 
(ORF)-specific DNA microarray using the publicly avai-
lable P. falciparum genome sequence. Each gene was 
represented by one or more long 70 mer oligonucleotides 
selected on the basis of uniqueness within the genome, 
exclusion of low-complexity sequence, balanced base 
composition and proximity to the 3' end. A first-generation 
microarray representing approximately 6,000 ORFs of the 
P. falciparum genome was constructed. Arrays were 
washed and scanned with GenePix 4000B and GenePix 
Pro 3.2 software normalized the data. Cluster analysis 
was done using the CLUSTER and TREEVIEW software 
(Esien et al., 1998) to extensively characterize the gene-
expression profile of the intra-erythrocytic trophozoite and 
schizont stages of P. falciparum. The results revealed 
extensive transcriptional regulation of genes specialized 
for processes specific to these two stages and may serve 
as the basis for future drug targets and vaccine develop-
ment. 
A good example of the ability of microarray analyses to 
monitor gene expression is provided by the study report-
ed in Bozdech et al. (2003a). They reasoned that profiling 
transcript abundance throughout the erythrocyte phase of 
the lifecycle of the malaria parasite, P. falciparum, might 
identify a handful of genes that are induced at critical 
times and hence might be novel drug targets. The 
Affymetrix Custom Express program enables researchers 
to use any available sequence information to create a 
GeneChip microarray focused on their specific research 
needs. Using the Affymetrix CustomExpress Array pro-
gram, Le Roch et al. (2003) created a customized 
GeneChip microarray, representing the complete genome  
 
 
 
 
of P. falciparum, to better understand global gene activity 
during the different stages of the P. falciparum life cycle 
that transfers from mosquito to man and back to mos-
quito. Having developed a custom P. falciparum Gene-
Chip microarray, the research team was able to examine 
the simultaneous activity of 95 percent of the 5300 genes 
present within the parasite. The first step was arranging 
genes based on their expression at different stages of the 
P. falciparum life cycle. They then identified groups of 
genes that were expressed at the same times and 
categorized them into 15 distinct 'clusters' using a robust 
k-means algorithm. 
Llinas et al. (2006) have used a genome-wide 
approach to characterize transcriptional differences bet-
ween strains of P. falciparum by characterizing the 
transcriptome of the 48h intraerythrocytic developmental 
cycle (IDC) for two strains, 3D7 and Dd2 and compared 
these results to HB3 strain obtained   from Bozdech et al. 
(2003a). These three strains originate from geographi-
cally diverse locations and possess distinct drug sensi-
tivity phenotypes. The majorities of these genes are 
uncharacterized and have no homology to other species. 
Strains 3D7 and Dd2, 60 and 58 DNA microarray hybridi-
zations were performed, respectively. The 3D7 dataset 
comprised of 53 hourly time points with hours 3, 15, 27, 
30, 32, 35 and 39 represented by more than one array 
hybridization. The Dd2 dataset were comprised of 50 time 
points with hours 4, 7, 12, 14, 20, 25, 28, 30 and 47 
represented by more than one array hybridization. DNA 
microarrays were scanned using an Axon 4000B scanner 
and images analyzed using Axon GenePix software to 
obtain raw microarray data for various strains P. 
falciparum.  
 
 
MICROARRAY TECHNOLOGY DEVELOPMENT 
EFFORTS IN AFRICA 
 
Microarray technology is making an inroad into techno-
logical development of some African countries but is 
highly hampered by the dearth of infrastructural develop-
ment and lack of technical human capital to carry out the 
required deliveries. It’s justifiable to say that Africans are 
beginning to understand the strength of microarray tech-
nology and genomics in general and its ability to solve 
peculiar challenges of disease and food. Strong linkages 
between genomics research and national malarial control 
programs will facilitate the translation of research findings 
into intervention tools. This new techno-logy awareness 
is important for the communities in endemic countries to 
have total understanding of genomics research in their 
healthcare system (Alibu and Egwang, 2003). 
A policy for developing biotechnology and genomics in 
a report entitled Biotechnology platforms: strategic review 
and forecast was launched in South Africa. The policy 
advocates the establishment of world-class genomics 
capacity, through the creation of a national facility and 
centres of excellence. The  New  Partnership  for  Africa’s  
  
 
 
 
Development (NEPAD) has likewise committed to deve-
loping regional capacity in science and technology, 
including genomics, using networks of centres of excel-
lence. The African Biosciences Facility in South Africa is 
a concrete achievement in this effort to make possible 
Africa’s active participation in the advances of genomics 
(WHO, 2005). Some other efforts include the formation of 
Nigeria Society of Bioinformatics and Computational 
Biology (NSBCB), African Society of Bioinformatics and 
Computational Biology (ASBCB). Organisation of geno-
mics conferences has also improved microarray tech-
nology in Africa, for example International Workshop on 
Pattern Discovery in Biology (IWPDB 2005 and 2009) at 
Covenant University, Ota, Ogun State, Nigeria; Bioinfor-
matics for Africa-Nairobi in 2007 and Mali in 2009 
respectively. Also included is a WHO/TDR sponsored 
functional genomics workshop (African Center for Train-
ing in Functional Genomics- AFRO VECTGEN) in Mali. 
It may be that such networks facilitate the development 
of more “networked” approaches to innovation including 
microarray technology and the provision of solution to the 
problem of malaria. To the best of our knowledge, South 
Africa seem to be ahead with an ACGT Microarray facility 
which exist at University of Pretoria and are involved in 
training and carrying out microarray study in organisms 
other than Plasmodium falciparum. A part WHO/TDR 
initiative, African Network for Drugs and Diagnostics 
Innovation (ANDI), was launched at Abuja, Nigeria in 
2008 (http://meeting.tropika.net/andi/) to promote & sus-
tain African-led R&D innovation through the discovery, 
development and delivery of affordable new tools include-
ing those based on traditional medicines. Malaria treat-
ment discovery is one of the major challenges facing this 
initiative. 
 
 
Conclusion 
 
It is obvious that using microarray technology affords 
great ease of analyzing the expression of batteries of 
microbial and malaria parasite genes at different phases 
of infection. Our ability to define virulence determinants 
and to understand how P. falciparum adapt and excel in 
their environments in mosquito and human by evading 
host defense mechanisms provides great hope to comba- 
ting this age-long disease in Africa. Both experimental and 
computational analysis of the sequence and micro-array 
data of the malarial parasite is released freely into public 
databases as soon as they are produced. Many Africans 
both at home and in the diaspora in spite of their chal-
lenges are increasingly improving themselves with this 
technology by getting involved in some Malaria Genome 
Projects. 
In silico antimalarial drug researchers (Osamor, 2009) 
are currently extracting vast amount of information from 
knowledge base available in microarray data for malaria 
treatment discovery in Africa. The time has come to con-
centrate on microarray analysis of the human malaria pa- 
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parasite with a view of eradicating the parasite in Africa 
and ultimately provide a home-grown solution to African 
problems through improved drug target and design stra-
tegies. ANDI is poised to sustain this African-led R&D 
innovation involving the development and use of new 
tools such as microarray technology. 
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